BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
about
The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motilityReduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomasFibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasionCleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein.Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4The pathobiology of glioma tumorsContributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer.Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.Brevican knockdown reduces late-stage glioma tumor aggressiveness.Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells.The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo.Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletionChondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopyProteoglycans and their roles in brain cancer.Biological functions of iduronic acid in chondroitin/dermatan sulfate.Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.ADAMTS expression and function in central nervous system injury and disorders.Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.Sugar glues for broken neuronsA new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice.High expression of ADAMTS5 is a potent marker for lymphatic invasion and lymph node metastasis in colorectal cancer.Hyaluronan-based extracellular matrix under conditions of homeostatic plasticity.
P2860
Q24607682-26E2D94F-7BB9-40F2-B19F-3591986BBD6DQ24648503-E54685E1-F95D-4D63-8859-F0E229C52B1DQ28263549-89A1EFBB-51EC-41BF-B61F-FEA606D38DFDQ33556306-01D3CCFC-2A30-46A2-8777-116106B4FAAEQ33648561-B7642E31-597B-4A78-A6F3-AC5A9A0D8FB2Q33921072-7A5D7F04-06CB-44C2-B223-B41A107D5B39Q34005886-0C15ADA0-98A7-4993-AF9D-9A759F9DDB85Q34100940-7B344CE9-9D99-4F1C-B30A-3C4602E2C066Q34198939-00568275-C8BC-4ACB-971E-CC3948856DF8Q34257738-8E144566-C80F-42E3-8DCE-6897032AE237Q34283551-B5C82391-6084-4D59-8902-EE51F65AB872Q34383355-F46E71B6-F4CC-490F-82ED-31BC34CD4EB0Q34518052-69BD8F08-788F-41E8-A536-2DD391576238Q34768858-D8512267-97BF-46F2-A53D-7FD4592B7F44Q35058206-E465AB26-BF1E-4B88-B86A-C5A88E039931Q35119552-FC9EA21D-18BD-45EC-9DA4-5A3BD34F1CE3Q35210355-94726464-1AAD-4429-9B07-97EA5EA13D44Q35679442-DBC4E9D3-8AE2-44D2-A7EC-22780CBB1134Q36398251-B5ED65FD-0886-4BCB-850E-188A832ADEFCQ36816444-76D2AE2D-C588-4599-BE07-6F234219D0C9Q37029047-E1C6456A-F991-48B4-B6A2-5F6218CC76F9Q37150545-ABE4FAE9-2DE5-4079-8D39-9B700995A2AFQ37229269-51D00250-DC1F-48EC-921F-2945AE6C7A40Q37346436-1355FA37-AA59-466A-A3E0-7BA546FBE049Q37494834-25490EE0-57DE-4C4D-A4B1-5F501533C812Q38256971-2B797D0A-9B2B-439E-94E7-2F97431DEB55Q38994539-92897B21-5227-4A4F-8D47-0C06E0FEADA6Q39697732-A6827E34-FDED-476F-82FF-97662EE7BEC0Q42046322-C0F3AC99-18F3-4724-B6A3-41B9D54134BDQ42068436-A85A205B-9F1A-49D7-A7FD-C5D3D1CEE772Q42707692-EA441824-FF17-4859-9520-46000C78755E
P2860
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@en
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@nl
type
label
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@en
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@nl
prefLabel
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@en
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
@nl
P2860
P1476
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion
@en
P2093
Russell Thomas Matthews
P2860
P2888
P304
P356
10.1007/S11060-008-9575-8
P577
2008-04-09T00:00:00Z